Share the post "DII Data: Stock Market today Insights for 05 Aug 2024"
| Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|---|
 |
Navigant Corporate Advisors | Alacrity Securities | Sell | 32K | 37.50 | Navigant Ir Services Private |
 |
Shah Metacorp | Citadel Securities India Markets Private | Buy | 2M | 6.17 | Na |
 |
Jubilant Pharmova | East Bridge Capital Master Fund I | Buy | 1M | 851.00 | East Bridge Capital Master Fund |
 |
Bajaj Consumer Care | Goldman Sachs Funds – Goldman Sachs India Equity Portfolio | Sell | 2M | 256.02 | Quant Mutual Fund |
| Quant Mutual Fund | Buy | 2M | 256.00 | Goldman Sachs Funds – Goldman Sachs India Equity Portfolio | ||
 |
Aavas Financiers | Smallcap World Fund Inc | Buy | 501K | 1630.00 | Na |
 |
Seacoast Shipping Services | Topgain Finance Private | Sell | 4M | 6.12 | Na |
The 32K shares of Navigant Corporate Advisors have been sold by the by Alacrity Securities through Domestic Investments at a price of ₹37.50 per shareand it is purchased by Navigant Ir Services Private at a price of ₹37.50 per share.
The 2M shares of Shah Metacorp have been purchased by the by Citadel Securities India Markets Private through Domestic Investments at a price of ₹6.17 per share.
The 1M shares of Jubilant Pharmova have been purchased by the by East Bridge Capital Master Fund I through Domestic Investments at a price of ₹851.00 per shareand it is sold by East Bridge Capital Master Fund at a price of ₹851.00 per share.
The 2M shares of Bajaj Consumer Care have been sold by the by Goldman Sachs Funds – Goldman Sachs India Equity Portfolio through Domestic Investments at a price of ₹256.02 per shareand it is purchased by Quant Mutual Fund at a price of ₹256.02 per share.
The 2M shares of Bajaj Consumer Care have been purchased by the by Quant Mutual Fund through Domestic Investments at a price of ₹256.00 per shareand it is sold by Goldman Sachs Funds – Goldman Sachs India Equity Portfolio at a price of ₹256.00 per share.
The 501K shares of Aavas Financiers have been purchased by the by Smallcap World Fund Inc through Domestic Investments at a price of ₹1630.00 per share.
The 4M shares of Seacoast Shipping Services have been sold by the by Topgain Finance Private through Domestic Investments at a price of ₹6.12 per share.
| Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|---|
|
Jubilant Pharmova | East Bridge Capital Master Fund I | Buy | 1M | 851.00 | East Bridge Capital Master Fund |
Jubilant Pharmova shares totaling 1M were purchased by the by East Bridge Capital Master Fund I of Domestic Investments, with the transaction occurring at a price of ₹851.00 per share. Subsequently, the shares were sold by East Bridge Capital Master Fund at the same price per share.
Shah Metacorp Limited
462.90
Net Sales
233.38
Net Profit
463.19
Total Income
436.81
Expenditure
5.12
Current Price
217
Market Cap
The latest financial figures for Shah Metacorp Limited indicate a strong performance. The company achieved net sales of ₹462.90 million and total income of ₹463.19 million for the quarter. Expenditure was ₹436.81 million, resulting in a net profit of ₹233.38 million. Earnings per Share (EPS) for continuing operations stood at ₹0.56. The report also shows other income of ₹0.29 million, finance costs of ₹0.06 million, and employee benefit expenses of ₹2.79 million. Depreciation and amortization expenses totaled ₹8.31 million. Current tax expense was ₹0.00 million and deferred tax expense was ₹41.22 million. Total comprehensive income for the period was ₹233.38 million, with other comprehensive income net of taxes at ₹0.00 million.
Currently valued at ₹217 crore, the company's stock price is ₹5.12. It has seen a price range of ₹7.40 / 2.51 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 41.8, implying a strong valuation. The book value per share is ₹1.37 and the dividend yield is 0.00%. ROCE is recorded at 25.8%, and ROE stands at 61.0%. The company maintains a very low debt-to-equity ratio of 0.64, though it has a negative net cash flow of ₹-28.3 crore. The Piotroski score of 6.00 and the Graham Number of ₹4.40 suggest some caution, while the Price-to-Book (P/B) ratio of 3.74 reflects a premium valuation.
Jubilant Pharmova Limited
17,317.00
Net Sales
4,818.00
Net Profit
17,457.00
Total Income
16,419.00
Expenditure
1,220
Current Price
19,424
Market Cap
The financial snapshot for Jubilant Pharmova Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹17,317.00 million and total income was ₹17,457.00 million. The company's expenditure was ₹16,419.00 million, leading to a net profit of ₹4,818.00 million. Earnings per Share (EPS) for continuing operations were ₹30.44. The report also highlights other income of ₹140.00 million, finance costs of ₹710.00 million, and employee benefit expenses of ₹5,529.00 million. Depreciation and amortization costs were ₹907.00 million, while current and deferred taxes were ₹261.00 million and ₹-82.00 million, respectively. The total comprehensive income for the period stood at ₹4,779.00 million, with other comprehensive income net of taxes at ₹-39.00 million.
With a market capitalization of ₹19,424 crore, the company’s stock is currently priced at ₹1,220. The historical trading range of the stock is ₹1,247 / 319. The P/E ratio is remarkably high at 83.0, suggesting a significant valuation. The book value stands at ₹341, and the dividend yield is 0.41%. The Return on Capital Employed (ROCE) is 6.74%, and the Return on Equity (ROE) is 0.76%. The debt-to-equity ratio is very low at 0.67, though the company shows a negative net cash flow of ₹-57.5 crore. The Piotroski score is 8.00, with the Graham Number pegged at ₹516. The Price-to-Book (P/B) ratio of 3.58 highlights a premium valuation.
Bajaj Consumer Care Limited
2,411.78
Net Sales
379.82
Net Profit
2,521.83
Total Income
2,061.60
Expenditure
258
Current Price
3,690
Market Cap
The latest financial figures for Bajaj Consumer Care Limited indicate a strong performance. The company achieved net sales of ₹2,411.78 million and total income of ₹2,521.83 million for the quarter. Expenditure was ₹2,061.60 million, resulting in a net profit of ₹379.82 million. Earnings per Share (EPS) for continuing operations stood at ₹2.66. The report also shows other income of ₹110.04 million, finance costs of ₹1.65 million, and employee benefit expenses of ₹270.30 million. Depreciation and amortization expenses totaled ₹22.27 million. Current tax expense was ₹80.41 million and deferred tax expense was ₹0.00 million. Total comprehensive income for the period was ₹379.82 million, with other comprehensive income net of taxes at ₹0.00 million.
Currently valued at ₹3,690 crore, the company's stock price is ₹258. It has seen a price range of ₹289 / 200 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 25.2, implying a strong valuation. The book value per share is ₹58.2 and the dividend yield is 1.16%. ROCE is recorded at 22.8%, and ROE stands at 18.8%. The company maintains a very low debt-to-equity ratio of 0.01, though it has a negative net cash flow of ₹8.76 crore. The Piotroski score of 8.00 and the Graham Number of ₹116 suggest some caution, while the Price-to-Book (P/B) ratio of 4.44 reflects a premium valuation.
 Ltd. logo1.jpg){kind=logo}
